News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Upstate Announces Four New Agreements To Provide KinaseProfiler Service; Leading-Edge Technology Accelerates Drug Discovery


10/19/2005 5:12:47 PM

ATLANTA--(BUSINESS WIRE)--Feb. 16, 2005--Serologicals Corporation (NASDAQ: SERO) today announced that Upstate Group, its wholly owned subsidiary, has entered into separate agreements to provide drug screening services to four companies -- Array Biopharma and three other significant multi-national pharmaceutical companies -- utilizing Upstate's KinaseProfiler(TM) service for determining selectivity and specificity of potentially therapeutic proprietary compounds.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES